Company intelligence / Profile preview

Gartmore Group

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Gartmore Group was a prominent British investment management firm that operated globally, offering a wide range of equity and alternative investment products. While not a biotechnology or pharmaceutical company itself, Gartmore was a significant institutional investor in the life sciences sector, managing specialized healthcare and biotech funds. The company was known for its active management style and its presence in the UK retail and institutional markets. In 2011, Gartmore was acquired by Henderson Group (now Janus Henderson), leading to the integration of its funds and the retirement of the Gartmore brand.

Industry: Investors

Beyond the preview

Go deeper on Gartmore Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gartmore Group.

Explore the full profile